ACADL and hepatocellular carcinoma: Consistently, re-expression of ACADL resulted in decreased YAP nuclear accumulation and YAP target genes expression in HCC xenograft tumors (Fig. 3f, g), that further confirmed the inhibitory effect of ACADL on YAP activity.